Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05633342
What this trial is testing

Project CADENCE (CAncer Detected Early caN be CurEd)

Who this might be right for
Thoracic CancerOvarian CancerLiver Cancer+6 more
MiRXES Pte Ltd 15,000
Testing effectiveness (Phase 2)Study completedNCT00215995
What this trial is testing

Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas

Who this might be right for
Esophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Testing effectiveness (Phase 2)Ended earlyNCT02392377
What this trial is testing

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Who this might be right for
Stage IB Esophageal AdenocarcinomaStage IIA Esophageal AdenocarcinomaStage IIB Esophageal Adenocarcinoma+3 more
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00827671
What this trial is testing

Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma

Who this might be right for
Resectable Esophageal Cancer
P.O. Witteveen 12
Testing effectiveness (Phase 2)UnknownNCT03224221
What this trial is testing

Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Anhui Medical University 189
Testing effectiveness (Phase 2)Study completedNCT03490292
What this trial is testing

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

Who this might be right for
Resectable Esophageal CancerGastroEsophageal Cancer
University of Wisconsin, Madison 22
Not applicableUnknownNCT03029793
What this trial is testing

Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer

Who this might be right for
Esophageal Cancer
Air Force Military Medical University, China 200
Early research (Phase 1)Study completedNCT01894763
What this trial is testing

Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia

Who this might be right for
Esophageal Cancer
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Not applicableStudy completedNCT03397745
What this trial is testing

Bispectral Index Throughout Esophageal Cancer Operation

Who this might be right for
Esophageal Cancer
Samsung Medical Center 44
Not applicableLooking for participantsNCT04354064
What this trial is testing

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Who this might be right for
Healthy VolunteerProstate CancerHead and Neck Cancer+10 more
Washington University School of Medicine 100
Not applicableStudy completedNCT01243619
What this trial is testing

FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Not applicableStudy completedNCT05403736
What this trial is testing

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Who this might be right for
Cancer
Cedars-Sinai Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Not applicableWithdrawnNCT04520867
What this trial is testing

STRENGTH Expansion

Who this might be right for
Esophageal CancerGastroesophageal Junction Cancer
University of Colorado, Denver
Next Page